18-JUN-2026 6:10

BREAST ACCRUAL REPORT - Open and Recently Closed Studies

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S2206-Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 1 Y 1 Tissue for MammaPrint testing 960 1083 525 269 132 34 4 11/27/2023 412 141
            1083 525 269 132 34 4      
 
    2 Y 2 SOC Chemotherapy   193 100 49 23 6 1 11/27/2023    
        3 SOC Chemotherapy + Durvalumab   190 98 47 24 4 0      
            383 198 96 47 10 1      
 
  S2212-Breast, TNBC, Neoadj Chemo + Pembro 1 Y 1 Carbo + Paclitaxel + Pembro -> AC + Pembro 2400 735 388 208 111 34 2 09/15/2023 431 158
        2 Carbo + Docetaxel + Pembro   732 381 207 109 29 6      
            1467 769 415 220 63 8      
 
Yes A011801-BRST, HER2+, T-DM1+Placebo v T-DM1+Tucatinib 1 E Total Registrations   55 0 0 0 0 0 03/11/2021 455 190
            55 0 0 0 0 0      
 
  A012103-Breast,StgT1cN1-2/T2-4N0-2,obsvsPembrolizumab 1 E Total Registrations   56 28 10 5 3 1 08/24/2023 442 189
            56 28 10 5 3 1      
 
  MA39-BREAST, Node-Pos, Reg RT vs No Reg RT 1 E Total Registrations   78 21 10 6 1 1 10/18/2019 402 148
            78 21 10 6 1 1      
 
    2 E Total Registrations   75 20 10 6 1 1 10/18/2019    
            75 20 10 6 1 1      
 
  NRGBR002-Brst, OMBC, II-III, SoC +/- SBRT and/or SA 1 T Total Registrations   1 0 0 0 0 0 09/22/2017    
            1 0 0 0 0 0      
 
  NRGBR005-Br, Stg II&IIIA, Post NAdj Chemo Br Conserv 1 T Total Registrations   7 0 0 0 0 0 06/22/2018    
            7 0 0 0 0 0      
 
No A012303-Breast, HER2+, Shortened Adj 1 E Total Registrations   4 4 4 3 1 0 03/06/2026 48 19
            4 4 4 3 1 0      
 
  NRGBR009-Breast, EarlyStg, Adjuvant Chemo 1 E Total Registrations   54 39 20 9 3 1 01/31/2024 525 204
            54 39 20 9 3 1      
 
    2 E Total Registrations   43 28 12 6 1 0 01/31/2024    
            43 28 12 6 1 0